Seed Investment Open • Patent Pending • Swiss MedTech

AI-Powered Cardiac
Screening for Primary Care

AuscultaNet transforms standard stethoscope recordings into actionable cardiac insights. Offline AI detects and classifies heart murmurs — including timing classification no other system provides.

91.7%

AUROC

82.2%

Sensitivity

84.1%

Specificity

100%

Offline

Today, 56% of significant heart valve disease goes undetected in primary care. AuscultaNet changes that.

Learn more

The Clinical Problem

Heart valve disease is the most commonly missed cardiac condition in primary care

56%

of significant valve disease goes undetected by primary care physicians

Diastolic murmurs are 100% pathological

Every diastolic murmur requires immediate cardiology referral, yet they are among the most frequently missed findings.

70–80% of systolic murmurs are innocent

Without timing classification, physicians cannot distinguish between innocent flow murmurs and those requiring intervention.

44% sensitivity in primary care

Studies show general practitioners detect fewer than half of clinically significant murmurs during routine auscultation.

Our Solution

Clinical decision support that fits into existing workflows

Step 1

Record

Standard 4-site cardiac auscultation with any digital stethoscope. Under 5 seconds per site.

Step 2

Analyse

On-device AI processes the recording instantly. No cloud, no internet, no patient data leaves the device.

Step 3

Decide

Receive murmur detection, timing classification, grade estimation, and a prioritised clinical recommendation.

AuscultaNet clinical interface — 4-site examination with combined clinical reasoning

Key Differentiators

What sets AuscultaNet apart

Timing Classification

Classifies murmurs as systolic, diastolic, or continuous — the clinical distinction that determines urgency of referral.

Fully Offline

All AI processing on-device. Complete data sovereignty. No infrastructure dependencies.

Benchmark Validated

Validated on public, reproducible datasets. Performance independently verifiable.

4-Site Clinical Workflow

Structured examination across Aortic, Pulmonic, Tricuspid, and Mitral sites with cross-site clinical reasoning.

Safety-First Design

Built-in escalation protocols. When in doubt, recommend echocardiography.

EHR Integration

FHIR R4 and HL7 compatible. Structured export for Swiss EPD and international EHR systems.

Performance

Validated on public benchmark datasets

Multi-task clinical model with 7 simultaneous outputs. Tested on standardised, publicly available data with proper patient-level splits and bootstrap confidence intervals.

Multi-Task Clinical Model • 7 Simultaneous Outputs

91.7%

AUROC

95% CI: 0.893 – 0.939 • Bootstrap n=1000

82.2%

Sensitivity

84.1%

Specificity

8,400+

Recordings

Our Partners

Supported by the Swiss innovation ecosystem

AuscultaNet is developed in Switzerland, supported by leading institutions for MedTech innovation, deep tech, and startup growth.

MedTech Booster

Startup Program

Technology Partner

🇨🇭 Swiss Trademark #838818 • Patent Pending

Regulatory

Pursuing clearance across three jurisdictions

FDA 510(k)

Established predicate pathway

CE Mark (MDR)

Class IIa Medical Device

Swissmedic

Conformity Assessment

Our Team

Swiss precision meets clinical expertise

A focused team combining AI engineering, regulatory strategy, and clinical cardiology.

Rachid Lagbila

Co-Founder & CEO

13+ years in safety-critical systems (automotive & MedTech). Experience with MDR and FDA 510(k) submissions. Leads regulatory and clinical strategy.

Mohamed Aymen Lagbila

Co-Founder & CDPO

Data & AI Engineer, Embedded System Architect, Azure-certified. Leads AI integration and device architecture.

Andrea Sparti

RA/QA Specialist

20+ years in medical device regulatory affairs. Former Ypsomed AG, leading FDA 510(k) and CE Mark submissions. Deep expertise in ISO 13485 QMS, EU MDR, and US market access.

Advisory Board

Dr. Dimitrios Chatzis

Medical Advisor

Consultant cardiologist. Leads pilot study planning in Greece and Cyprus. Signed LOI.

Get Involved

Two ways to join the mission

For Investors

Seed round open to fund clinical validation and regulatory clearance. Join leading MedTech-focused investors in closing the cardiac diagnostic gap.

Multi-billion-dollar addressable market (cardiac diagnostics)
Established reimbursement precedent (CPT 0962T, $128.90/use)
Clear regulatory pathway to FDA clearance via 510(k)

For Clinics & Researchers

Join our prospective multi-site validation study. We are recruiting partner institutions for a clinical trial comparing AuscultaNet to echocardiography as gold standard.

Co-authorship on peer-reviewed publications
Free access to AuscultaNet during validation period
4-site protocol: Aortic, Pulmonic, Tricuspid, Mitral

From the AuscultaNet team

Milestone Jan 2026

AuscultaNet Joins SITEM MedTech Booster

Selected for Switzerland's leading MedTech acceleration program, providing regulatory mentorship, clinical infrastructure, and access to the Swiss hospital network.

Research 2025

Why 56% of Valve Disease Goes Undetected

An evidence-based analysis of the diagnostic gap in primary care auscultation — and how AI-powered timing classification changes the equation.

Clinical 2025

Understanding Heart Murmur Timing

Why the distinction between systolic, diastolic, and continuous murmurs is the most critical decision point in cardiac auscultation.

Ready to transform cardiac screening?

Join us in closing the diagnostic gap in primary care.

AI-Powered CardiacScreening for Primary Care